Related Experiment Videos
Optimal frequency of topical prednisolone administration
Archives of Ophthalmology (Chicago, Ill. : 1960)
|November 1, 1979
Summary
Hourly administration of prednisolone acetate ophthalmic suspension significantly reduced corneal inflammation. Frequent, short-interval dosing (every 15 minutes or five times hourly) provided the greatest reduction in polymorphonuclear leukocytes, indicating superior anti-inflammatory effects.
Area of Science:
- Ophthalmology
- Pharmacology
- Inflammation Research
Background:
- Corticosteroids are widely used for ocular inflammation.
- Prednisolone acetate is a common ophthalmic corticosteroid.
- Understanding optimal dosing frequency is crucial for efficacy.
Purpose of the Study:
- To investigate the relationship between the frequency of prednisolone acetate ophthalmic suspension instillation and its anti-inflammatory effect in the cornea.
- To compare the efficacy of different dosing intervals (hourly, 15-minute, and 4-hour intervals).
Main Methods:
- Experimental study involving topical administration of 0.125% and 1.0% prednisolone acetate ophthalmic suspensions.
- Evaluation of anti-inflammatory effect by quantifying polymorphonuclear leukocytes in the cornea.
- Comparison of dosing frequencies including 4-hour, 1-hour, 15-minute intervals, and a regimen of five doses per hour at one-minute intervals.
Main Results:
- Four-hour intervals failed to produce a significant anti-inflammatory effect.
- Hourly administration of both concentrations showed a substantial anti-inflammatory effect.
- 15-minute intervals resulted in a significantly greater reduction of corneal polymorphonuclear leukocytes compared to hourly administration (P < .05).
- A regimen of five hourly doses at one-minute intervals achieved an anti-inflammatory effect comparable to 15-minute intervals.
Conclusions:
- Dosing frequency significantly impacts the anti-inflammatory efficacy of prednisolone acetate ophthalmic suspension.
- More frequent administration, particularly at 15-minute intervals or in a pulsed hourly regimen, enhances therapeutic effects in the cornea.
- These findings suggest optimized dosing strategies for managing ocular inflammation with prednisolone acetate.